SCHEMBL8287604

SCHEMBL8287604

CC(=O)CCc1nc(C)cc2c1c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.37
GAA P10253 6/20 0.36
HPGD P15428 3/20 0.36
MAPK1 P28482 2/20 0.36
GFER P55789 1/20 0.36
MAPT P10636 4/20 0.35
NPC1 O15118 2/20 0.35
ALDH1A1 P00352 4/20 0.35
KDM4E B2RXH2 4/20 0.35
LMNA P02545 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
CLK1 P49759 1/20 0.35
RAB9A P51151 1/20 0.35
HTT P42858 3/20 0.34
NPSR1 Q6W5P4 2/20 0.34
ATM Q13315 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287209 0.93 PLA2G4A (0.38) PDE11AGAAHPGDMAPK1GFER
SCHEMBL8287607 0.91 PDE11A (0.37) PDE11AGAAHPGDMAPK1GFER
SCHEMBL8287533 0.90 SLC2A1 (0.44) GAAHPGDMAPK1MAPTALDH1A1
SCHEMBL8287527 0.90 TSHR (0.39) PDE11AGAAHPGDMAPK1GFER
SCHEMBL8287571 0.90 NR4A2 (0.37) PDE11AGAAHPGDMAPK1GFER
SCHEMBL8287610 0.87 PDE11A (0.39) PDE11AGAAHPGDMAPK1MAPT
SCHEMBL8287190 0.86 PDE11A (0.40) PDE11AGAAHPGDMAPK1GFER
SCHEMBL8287535 0.86 PDE4B (0.41) PDE11AGAAHPGDMAPTNPC1
SCHEMBL8286460 0.85 PDE11A (0.43) PDE11AGAAHPGDMAPK1GFER
SCHEMBL8286421 0.83 PDE11A (0.39) PDE11AGAAHPGDMAPK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed